Other operating income (excl. revaluation income and releases from provisions) and financial income from operating receivables
35,788,033
21,487,720
4.
Net claims payments in the period
31
-330,096,400
-293,880,632
5.
Expenses for bonuses and rebates
288,628
5,848
6.
Net operating expenses excl. depreciation/amortisation and change in deferred acquisition costs
33
-174,475,963
-151,825,973
7.
Investment expenses (excluding amortisation and financial expenses)
-119,291
-54,102
8.
Other operating expenses excl. depreciation/amortisation (other than for revaluation and excl. additions to provisions)
34
-26,179,690
-20,428,503
9.
Tax on profit and other taxes not included in operating expenses
35
-12,248,723
-8,786,075
b)
Changes in net operating assets (receivables for premium, other receivables, other assets and deferred tax assets/liabilities) of operating items of the income statement
-12,065,157
1,698,017
1.
Change in receivables from primary insurance
10
-2,209,214
-72,983,726
2.
Change in receivables from reinsurance
10
361,919
61,807,865
3.
Change in other receivables from (re)insurance business
10
-532,222
365,290
4.
Change in other receivables and other assets
10
269,601
-2,880,757
5.
Change in deferred tax assets
3
157,319
218,499
6.
Change in inventories
-5,395
-28,879
7.
Change in liabilities arising out of primary insurance
25
-10,432,775
42,801,036
8.
Change in liabilities arising out of reinsurance business
25
1,015,849
-31,132,515
9.
Change in other operating liabilities
26
-524,718
-2,442,917
10.
Change in other liabilities (except unearned premiums)
2
2,086,738
6,231,258
11.
Change in deferred tax liabilities
3
-2,252,259
-257,137
c)
Net cash from/used in operating activities (a + b)
330,719
31,350,157
B.
Cash flows from investing activities
a)
Cash receipts from investing activities
1,657,653,508
1,416,437,638
1.
Interest received from investing activities
16,459,186
18,607,327
2.
Cash receipts from dividends and participation in the profit of others
1,378,367
1,141,433
4.
Proceeds from sale of property, plant and equipment
4,156,317
2,707,118
5.
Proceeds from sale of financial investments
1,635,659,638
1,393,981,760
b)
Cash disbursements in investing activities
-1,620,282,746
-1,405,529,717
1.
Purchase of intangible assets
-1,547,018
-1,177,107
2.
Purchase of property, plant and equipment
-2,761,542
-4,833,554
3.
Purchase of long-term financial investments
-1,615,974,186
-1,399,519,056
c)
Net cash from/used in investing activities (a + b)
37,370,762
10,907,921
C.
Cash flows from financing activities
b)
Cash disbursements in financing activities
-12,426,602
-38,241,119
1.
Interest paid
-28,445
-718,860
3.
Repayment of long-term financial liabilities
0
-24,000,000
4.
Repayment of short-term financial liabilities
0
-1,058,233
5.
Dividends and other profit participations paid
-12,398,157
-12,464,026
c)
Net cash from/used in financing activities (a + b)
-12,426,602
-38,241,119
D.
Closing balance of cash and cash equivalents
64,657,431
37,956,119
x)
Net increase/decrease in cash and cash equivalents for the period (Ac + Bc + Cc)
25,274,879
4,016,959
y)
Opening balance of cash and cash equivalents
37,956,119
33,939,160
Opening balance of cash and cash equivalents – acquisition
1,426,433
0
The notes to the financial statements in sections from 17.4 to 17.11 form an integral part of these financial statements.
